The HSRAANZ’s awards and prizes program recognises individuals who have made significant contributions to the fields of health services research and health policy in Australia and New Zealand.

To discuss sponsorship of any of the following awards please contact Sarah Green on 02 9514 4723/email

    Past Winners of HSRAANZ Awards and Prizes

  • HSRAANZ Professional Award

  • 2019 Distinguished Investigator Awards

  • 2019 Best Papers

    Best PhD Paper 


    Jonathan Kaufman, Royal Children’s Hospital, Melbourne

    Liquid Gold: the cost-effectiveness of urine sample collection methods for young pre-continent children (READ MORE)

    Highly Commended

    Jodie Bailie, University Centre for Rural Health, University of Sydney,

    Comparing and contrasting innovation platforms with other forms of professional networks for strengthening primary healthcare systems for Indigenous Australians. (READ MORE)

    Michelle Tew, Centre for Health Policy, Melbourne

    Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients (READ MORE)

    Best ECR Paper 


    Sopany Saing, Centre for Healt Economics Research & Evaluation,  UTS

    Real World Cost Effectiveness of Mandatory Folic Acid Fortification of Bread Making Flour in Australia (READ MORE)

    Highly Commended

    Khic-Houy Prang, Centre for Health Policy Melbourne

    The use of public performance reporting by general practitioners: a study of perceptions and referral behaviours (READ MORE)

    Andrea Schaffer Centre for Big Data in Healht, UNSW

    Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics (READ MORE)

    Best Overall Papers

    Quantitative Winner

    Sue Kidea,Charles Darwin University, Queensland

    Reducing preterm birth amongst Aboriginal and Torres Strait Islander babies: A prospective cohort study, Brisbane, Australia (READ MORE)

    Qualitative Winner

    Kristie Weir, Wiser Healthcare, Sydney School of Public Health, The University of Sydney

    Decision-Making Preferences and Deprescribing: Perspectives of Older Adults and Companions About Their Medicines (READ MORE)

    Highly Commended

    Katherine Harding, Eastern Health /La Trobe University

    A model of access combining triage with initial management reduced waiting time for community outpatient services: a stepped wedge cluster randomised controlled trial (READ MORE)

  • 2019 Conference Awards

    Best Abstract at the 11th Health Services and Policy Research Conference

    Cervante Wild, Liggins Inst, Uni Auckland

    Understanding barriers and facilitators to engagement in a multi-disciplinary service for childhood obesity (READ More)

    Cervante Wilde Best Abstract Winner
    Best Abstract Highly Comended
    Philippa Dalach,  Centre for Health Policy, Melbourne

    Improving Genetic Health Services for Aboriginal and Torre Strait Islander people in three Australian States: Using Consumer and Practitioner Experiences to Design Culturally Safe Policy (READ MORE)

    Philippa Dalach, Best Abstract People's Choice

    Best Poster


    Jingjine He

    Jinjing He Best Poster Winner

    Jinjing He Best Poster Winner3MT Competition


    Amy Brown

    Amy Brown, 3MT Competition Winner

    People's Choice

    Johnathan Kaufma

    Jonathan Kaufman, 3MT Competition, People's Choice

  • 2018 Award Winners

    The HSR Impact Award

    This biennial award recognises health services research that has had a significant impact through translation into health policy, management, or clinical practice.   We received seven very worthy nominations that that highlight the amazing real-world impact of health services research. The submissions covered a broad range of impacts and after the judges' votes had been cast, we had a tie between two very different pieces of HSR.

    Dr Elizabeth Lynch

    Dr Elizabeth Lynch and colleagues for a program of research around the implementation of the nationally recommended Assessment for Rehabilitation Tool.  As part of a RCT, she identified that rehab needs were being made based primarily on the services available.  Elizabeth’s subsequent engagement with stakeholders focused on supporting clinicians to use the tool to identify unmet needs,  including a lead role in updating the stroke clinical guidelines with respect to the assessment of rehab needs.


    Dr Elizabeth Lynch  (Bio) 

     “Assessing and managing rehabilitation needs of people with stroke in Australia”

    Read Elizabeth's blog - Assessing and managing rehabilitation needs of people with stroke in Australia 

    Catherine Joyce on behalf of Anthony Scott

    Professor Tony Scott and his team involved in the development and maintenance of the Medicine in Australia: Balancing Employment and Life (MABEL) survey which is Australia's national panel survey of 10,000 doctors that has been running for over 10 annual Waves. The specific application of the project that was cited in the submission was the use of MABEL data to develop the Modified Monash Model (MMM), a new geographic classification scheme to allocate funding to medical workforce programs in rural areas. The MMM was first used by the Department of Health in 2015, and is now applied to over 15 workforce programs that allocate over $1bn to support access to medical care rural areas in Australia.

    Prof Anthony Scott    (Bio)

    Medicine in Australia: Balancing Employment and Life (MABEL).

    Read Anthony's blog - Influencing policy through research: Medicine in Australia: Balancing Employment and Life (MABEL)

    Best Health Services and Policy Research Papers

    These awards recognise the best scientific works in the field health services and policy research.

    Overall, ECR and PhD Student Categories

    Seven nominations were received for the overall best paper and eight for the ECR category.  There were some very strong submissions and judging was tight.  Research types included cost-effectiveness, outcomes research, meta-analysis, predictive modelling and qualitative research.

    Eleven papers were submitted for the PhD Student category and all were of a good standard. All except one was quantitative and several were analyses of large data sets. The winner was of the latter type and literally just pipped some of the other papers because it had good logical flow, clear concise language and clearly explained its relevance to policy and practice.

    Overall Winner - Alison Pearce

    Freddy Sitas on behalf of Alison Pearce

    Alison's winning paper estimates the years of productive life lost and assorted costs due to adult cancer deaths.  The paper compares estimates for 5 developing countries and across cancer subtypes.  The article impressed the judges in the scope of research undertaken and the value it will contribute to the research field, including its potential to guide local prevention and treatment strategies.
    Pearce, AM, Sharp, L, Hanly, P, Barchuk, A, Bray, F, de Camargo Cancela, M, Gupta, P, Meheus, F, Qiao, YL, Sitas, F, Wang, SM & Soerjomataram, I 2018,
    ‘Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison’, Cancer Epidemiology, vol. 53, pp. 27-34.   Publisher's site

    Read Alison's Blog  -$46 billion in productivity lost to cancer in developing countries

    ECR Winner - Haitham Tuffaha

    Haitham Tuffaha

    Haitham's paper presents a Markov model to estimate the long-term benefits and costs of testing women and their relatives with breast cancer who had at least a 10% probability of BRCA mutation.  This work struck the judging panel as of high importance to guide expensive treatment decisions.
    Tuffaha, Mitchell, Ward, Connelly, Butler, Norris, Scuffham
    ‘Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers’. Genet Med. 2018 Sep;20(9):985-994. doi: 10.1038/gim.2017.231. Epub 2018 Jan 4.  Publisher’s Site

    Read Haitham's blog - Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers

    PhD Student Winner - Tim Badgery-Parker

    Tim Badgery-Parker

    As the name suggests, Tim's paper is an analysis of a large dataset to examine the use of 27 low-value care procedures in Australian public Hospitals. The procedures studies varied substantially and included some very well-known and some less well-known procedures and used the perspective of the health service provider. Tim’s results show 13 of the procedures had negligible low-value care, 7 showed a decreasing trend, 4 had no clear trend and 3 showed an increasing trend for low-value care. However, there was substantial variation between hospitals.
    Badgery-Parker T, Pearson S, Chalmers K, et al
    Low-value care in Australian public hospitals: prevalence and trends over time BMJ Qual Saf Published Online First: 06 August 2018. doi: 10.1136/bmjqs-2018-008338  Publishers Site

    Read Tim's Blog -Measuring Low-Value Care

    PhD Student-Highly Commended Johnathan Brett

    Natasha Donnolley on behalf of Johnathan Brett

    Jonathan Brett, Helga Zoega, Nicholas Buckley, Benjamin Daniels, Adam Elshaug, Sallie-Anne Pearson
    Choosing Wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia

  • 2017 Award Winners

    2017 HSRAANZ Award Winners

    HSRAANZ Distinguished Investigator Awards

    The HSRAANZ Distinguished Investigator Awards recognize researchers who have made a significant contribution to the field of health services and health policy research in Australia and New Zealand through scholarship and teaching, advancement of science and methods, and leadership (relative to level of award).

    Life Time Achievement - Professor Libby Roughead

    Professor Libby Roughead, Research ProfessorSchool of Pharmacy and Medical Sciences, University of South Australia has developed a strong research agenda through her leadership of the Quality Use of Medicines and Pharmacy Research Centre (QUMPRC). Appointed Director in 2011, she currently leads a multidisciplinary team of 26 research and support staff and eight PhD students. With more than 200 research papers assessing harms associated with medicine used and over $50m in research funding, Libby has established an exceptional record of research translation into both policy and practice. Her translation successes are due largely to working directly with policy makers and government.

    Libby’s impact on policy and practice is extensive. Her research on medication safety has underpinned Australia’s health goals and targets and the current work plan in medication safety for the Australian Commission on Safety and Quality in Health Care (ACSQHC). Her 2015 report on medication safety in mental health is being used by ACSQHC to develop a work program in this area. Her research quantifying the extent of treatment conflicts in people with multimorbidity led Therapeutic Guidelines Ltd to develop a work plan for inclusion of multimorbidity in Australia’s national guidelines. Her research on interventions for improving use of medicines supported funding of home medicine reviews in Australia and provided the model for the sustained implementation of the Veterans’ Medicines Advice and Therapeutics Education Services (MATES) project, provided by the Australian Government Department of Veterans’ Affairs. The Veterans’ MATES program, which was re-funded in 2016, has implemented over 40 interventions, targeted every general practitioner, pharmacy, aged-care facility and veteran in Australia and resulted in measureable improvements in veteran health and net cost savings.

    Libby has made a significant contribution to the profession of health services research through her active engagement on national committees, such as Australia’s Drug Utilisation Subcommittee (member since 2001) and her board membership of Therapeutic Guidelines Ltd, a national body providing guidelines for Australian health professionals.

    Libby has supervised 7 PhD students to completion, has 4 current PhD students and has hosted extended visits by 8 international researchers during the last five years. Libby has a successful track record in identifying, recruiting, training and mentoring early career post-doctoral fellows who have been identified by her as having capacity for independent research and future leadership roles.

    Libby leads The Medicine and Device Surveillance CRE a collaboration multi-national collaboration between UniSA, University of Adelaide, Flinders University, University of Western Australia, Royal Adelaide Hospital and the National Prescribing Service, Harvard Medical School USA, University of Tokyo Japan, Seoul National University Korea, and the National Cheng Kung University Taiwan which has resulted in 47 publications and the development of the Asian Pharmacoepidemiology Network (AsPEN).

    Unfortunately Libby was unable to attend the HSRAANZ Conference to accept her award but our President Jon Karnon caught up with Libby in Adelaide to discuss her research career and present her award.

    Mid-Career Award - Professor Amanda Wheeler 

    Professor Amanda Wheeler is the Professor of Mental Health, Griffith University, University of Auckland (Clinical/Professor)

    Professor Wheeler has worked as a health practitioner, educator and researcher in mental health and pharmacy practice for almost 20 years. After establishing a highly successful research centre in a public health service in NZ that she directed for over 10 years, Amanda was awarded her PhD in 2009. Despite a late start to a publishing career, Amanda has made a significant contribution to health services & health policy research, with a key focus on reducing the burden of disease and treatment burden for people experiencing mental illness, and the delivery of person-centred care in the community pharmacy setting. She is nationally and internationally recognised for her expertise in these areas.

    Since 2004, Amanda has obtained four competitive national research grants totalling almost $4.5 million, published over 115 peer-reviewed papers (31 as first author, 5 solo-authored), 30 published abstracts/letters and delivered oral presentations at more than 35 conferences and meetings. Thirty-three publications to date have emanated from two Federal Department of Health grants, of which she was lead investigator. Amanda’s publications are well cited (900 citations) with an h-index of 20. Significant outcomes from her research work leading to practice changes include: development and validation of a consumer outcome tool that has been incorporated by the NZ Ministry of Health as part of the national suite of outcome measures in mental health services; development and implementation of best-practice guidelines for the use of the antipsychotic clozapine which were recommended by NZ Coronial Services in 2010 to be made available nationally; developed and implemented an audit and feedback cycle for antipsychotic use in schizophrenia that led to sustained, evidence-based changes in prescribing practice; developed and evaluated an on-line mental health continuing education programme for more than 600 Australian community pharmacy staff. In 2013 she was awarded a Griffith Health Excellence Award for outstanding research success
    and work in the area of mental health and addictions.

    Amanda provides a significant amount of time and effort to mentor students through the research journey. She has supervised 2 PhD and 2 MPhil graduates and is currently the convenor of the Higher Degree Research Program at the School of Human Services and Social Work at Griffith University. Amanda’s leadership skills have been recognised by fellowships with the UK College of Mental Health Pharmacy and the European Society for Person Centred Healthcare, appointments to the Advisory Committee on Medicines Scheduling for the Australian TGA, as Chair of the Clinical Pharmacy Group of the European Society for Person Centred Healthcare, and journal Editorial Board membership (The Patient and Journal of Pharmaceutical Policy and Practice). Her dedication to all facets of health services research makes Amanda a worthy recipient of such a prestigious award.

    HSRAANZ Best Health Services and Policy Research Papers

    Best Overall Paper - Jing Jing He

    He, J., et al. Improving patient flow and satisfaction: An evidence-based pre-admission clinic and
    transfer of care pathway for elective surgery patients. Collegian (2017),

    Bio: Jing Jing He is a research nurse at Macquarie University Hospital and a PhD candidate at the University of Sydney.  Jing graduated with First Class Honours in Nursing from the University of Sydney.  As a nurse, Jing has worked in various specialties include day surgery, cardiology, community nursing and clinical trials.  In 2014, she was appointed by Macquarie University Hospital as the research coordinator for the Pre-Admission Clinic Project (funded by the HCF Research Foundation). She has successfully led the project and implemented a triage system and discharge pathway for elective surgery patients.  Jing has a particular interest in clinical health innovations and using advanced technologies to improve patient outcome and practice efficiency.  Her PhD study focuses on the impact of chemotherapy-induced alopecia and a scalp cooling device on adult oncology patients.

    Jing Jing He receiving her award from HSRAANZ VPLaura Wilkinson-Meyers


    Aims: To redesign, implement and evaluate a Pre-Admission Clinic incorporated with a Transfer of Care Pathway for elective surgery patients.

    Methods: An evidence-based approach was used to redesign the Pre-Admission Clinic and the Transfer of Care Pathway. The impact of the pre-admission clinic and the care pathway was evaluated. De-identified data containing patient outcomes was collected from the hospital electronic medical record system from May 2014 to March 2015. Outcome measures included surgical cancellations, last-minute can-cellations, average length of stay, discharge delays, and adverse events that were compared pre and post-implementation. Patient satisfaction was measured pre and post-implementation by using a mod-ified version of Best Practice hospital survey.

    Results: A total of 10,854 eligible cases were included (5716 in the pre-implementation period and 5138 in the post-implementation period). The overall cancellation rate remained relatively stable (p = 0.95), however, the last-minute cancellation rate was reduced post-implementation (p = 0.02). Although no difference was observed in average length of stay (p = 0.39), the percentage of discharge delays was reduced (p = 0.027). The incidence of adverse events was too low to draw statistical conclusion. A sample of 102 patients completed the patient satisfaction survey. The overall satisfaction improved post-implementation (p = 0.03).

    Conclusions: The evidence-based Pre-Admission Clinic and the Transfer of Care Pathway had a positive impact on last-minute surgical cancellations, discharge delays and patient satisfaction.

    Best ECR Paper  - Dr Erin Penno

    Penno E, Gauld R. The role, costs and value for money of external
    consultancies in the health sector: A study of New Zealand’s District Health Boards. Health Policy (2017),

    Erin Penno

    Bio: Following a background working in the health sector in both the United Kingdom and New Zealand, Erin recently completed a PhD in public health at the University of Otago. She is currently a Research Fellow in the Dean’s Office in the Otago Business School where her research focuses on health funding, policy and systems.


    This paper examines spending on external consultancies in each of New Zealand’s 20 District Health Boards (DHB). Using evidence obtained from DHBs, it provides an insight into the cost and activities of consultants within the New Zealand health sector, the policies behind their engagement and the processes in place to ensure value for money. It finds that DHB spending on external consultants is substantial, at $NZ10–60 million annually. However, few DHBs had policies governing when consultants should be engaged and many were unable to easily identify the extent or purpose of consultancies within their organisation, making it difficult to derive an accurate picture of consultant activity throughout the DHB sector. Policies surrounding value for money were uncommon and, where present, were rarely applied. Given the large sums being spent by New Zealand’s DHBs, and assuming expenditure is similar in othe r health systems, the findings point to the need for greater accountability for expenditure and better evidence of value for money of consultancies within publicly funded health systems.

    Best Paper by a PhD Student - Ms Priya Martin

    Martin, P., Kumar, S., Lizarondo, L. and Tyack, Z. (2016), Factors influencing the perceived quality of clinical supervision of occupational therapists in a large Australian state. Aust Occup Ther J, 63: 338–346. doi:10.1111/1440-1630.12314 Link

    Priya Martin receiving her award from HSRAANZ VP Laura Wilkinson-Meyers

    Bio: Priya is an occupational therapist who has worked in a number of clinical, teaching, training and research roles in Australia and overseas. She currently works as a research officer with the Queensland Rural Generalist Pathway in Toowoomba, Queensland. She is also a PhD candidate with the University of South Australia. Her PhD research investigates the factors that contribute to high quality clinical supervision in allied health. She has expertise in interprofessional education, health professional education and training, curriculum development, mixed methods research designs and rural and remote workforce issues. She is increasingly being recognised as an international leader in the research and practice of clinical supervision.


    Background/aim: Clinical supervision is important for effective health service delivery, professional development and practice. Despite its importance there is a lack of evidence regarding the factors that improve its quality. This study aimed to investigate the factors that influence the quality of linical supervision of occupational therapists employed in a large public sector health service covering mental health, paediatrics, adult physical and other practice areas.

    Methods: A mixed method, sequential explanatory study design was used consisting of two phases. This article reports the quantitative phase (Phase One) which involved administration of the Manchester Clinical Supervision Scale (MCSS-26) to 207 occupational therapists.

    Results: Frequency of supervision sessions, choice of super- visor and the type of supervision were found to be the predictor variables with a positive and significant influence on the quality of clinical supervision. Factors such as age, length of supervision and the area of practice were found to be the predictor variables with a negative and significant influence on the quality of clinical supervision.

    Conclusion: Factors that influence the perceived quality of clinical supervision among occupational therapists have been identified. High quality clinical supervision is an important component of clinical governance and has been shown to be beneficial to practitioners, patients and the organisation. Information on factors that make clinical supervision effective identified in this study can be added to existing supervision training and practices to improve the quality of clinical supervision.

    We will be featuring more on our winning papers and authors over the next few weeks.

    Best Abstracts at HSR17

    As part of the peer review process for the Conference the scientific committee identified the highest ranked abstract overall and from an emerging researcher.

    Best Abstract Overall - Thomas Elliott Senior Research Assistant, QIMR Berghofer Medical Research Institute 

    Using a hybrid discrete-event /agent-based model to examine improved triaging of GPreferred patients to colonoscopies
    Thomas Elliott1, Anton Lord1, Lisa Simms1, Graham Radford-Smith2, L.Gordon1
    1QIMR Berghofer Medical Research Institute; 2Royal Brisbane and Women’s Hospital

    Thomas Elliott

    Background: Demand for colonoscopy services is placing significant pressure on health resources in Australia with over 700,000 procedures annually and costing over $1.1 billion. Current triaging processes do not effectively discriminate patients who will or will not show significant bowl disease (SBD). A new risk assessment tool may improve system efficiency and enhance patient care.

    Methods: We constructed a hybrid discrete event/agent-based model in AnyLogic software to simulate the GP-referral patterns, triaging, appointment booking, waiting times and costs for colonoscopies at the Royal Brisbane and Womens’ Hospital (RBWH). Using data from a cohort study of 466 GP-referred patients with lower abdominal symptoms, we utilised a newly designed clinical risk assessment tool (RAT) to model the current inefficiency in treatment urgency categorisation. The RAT had a specificity of 98%, showing its appropriateness for use as a rule-in test. We examined the RAT’s effect on waiting times and costs through simulation modelling at the hospital system

    Results: Approximately 2,200 patients referred to the colonoscopy clinic at the RBWH are treated each year. The RAT improved triaging for 9% of moderate urgent and 4% of least urgent patients. Over a year approximately 89 patients with SBD could receive more timely care. Moderately urgent patients with SBD received care 121 days earlier, while least urgent patients received care 114 days earlier.

    Conclusion: Our preliminary analyses indicate the RAT has significant potential to improve the coordination of patient care, improve patient outcomes, spare some patients from colonoscopies, while also saving substantial hospital expenditure.


    Best Abstract from an Early Career Researcher - Grace Kyoon-Achan University of Manitoba

    Journeys to healthcare transformation: Partnering for change through Community based Participatory Research with Manitoba First Nations
    Grace Kyoon-Achan1, Josée G. Lavoie1, Kathi Avery Kinew2, Stephanie Sinclair2
    1University of Manitoba; 2First Nations Health and Social Secretariat of Manitoba

    Grace Kyoon-Achan


    Background: Community-based participatory research can help support communities’ efforts in the formulation and implementation of innovative and transformative change. We share a collaborative journey in our work with eight (8) First Nations in Manitoba Canada who were seeking to improve the health of their communities. Participating communities wanted to produce evidence to move toward good health as they define it and to inform changes in healthcare based on community input on how to improve the health of their respective communities.

    Methods: Indigenous knowledges and processes guided data gathering and analysis. Community based participatory methods were used for the conceptualization of the study, data collection, analyses and knowledge translation. A variety of methods were used including: qualitative interviews, administrative health data analyses, surveys and case studies depending on the needs of the studies and the interests of different First Nation stakeholders, health directors and researchers.

    Results: Research relationships built upon strong ethics and locally recognized protocols enhance mutual commitment to support community-driven transformation. Collaborative and respectful relationships are platforms for defining and strengthening First Nations health and healthcare priorities. This is an important step in building long term changes that will be sustained long after research projects come to an end.

    Conclusion: This study yielded a blueprint for respectful community-based participatory research
    involving First Nations peoples, communities, University-based researchers and First Nations
    community-based researchers. The result is a locally owned yet widely recognized process that is
    effective and sustainable while also having fulfilled researchers and funding obligations.

    Highly Commended - Tim Tenbensel   University of Auckland       

    Gaming the New Zealand Emergency Department target. How did it vary between hospitals, and why?
    Tim Tenbensel1, Peter Jones2, Linda Chalmers2, Sarah Appleton-Dyer1, Lisa Walton1
    1University of Auckland’ 2Auckland District Health Board

    Background: New Zealand’s Shorter Stays in Emergency Departments target was implemented from 2009 to address ED crowding. The target required 95% of patients to be seen, treated or discharged within six hours. ‘Gaming’ is commonly regarded as an undesirable side-effect of using targets to drive health service improvement.

    Aims: Our research sought to identify the presence and extent of gaming after the target’s implementation, and explain variation in gaming across four case-study sites.

    Methods: We adopted a mixed-methods approach. To track the extent of gaming, ED utilisation data was collected from four case study hospitals from 2007 (two years pre-target) to 2012. Rates of pretarget ‘spikes’ and ‘digit preference bias’ were derived from this data. We conducted 68 semistructured interviews about target implementation with ED and hospital clinicians and managers in 2011 and 2012.

    Results: Significant ‘spikes’ of the proportion of ED discharges for the time interval immediately prior to the six hour target appeared in all sites after the target’s introduction. At all sites, patients were taken off the target stream (eg moved to short-stay units) to avoid target breaches. However, lower levels of gaming were associated with sites that adopted a ‘whole-of-hospital’ approach to target implementation. Gaming was more prevalent where implementation focused solely on ED staff and processes, without additional resources.

    Conclusion: While gaming occurred in all sites, our research demonstrates that a myopic focus on avoiding target breaches within ED accentuates gaming, whereas more holistic approaches to target implementation and additional resources help to reduce it.

    Three Minute Thesis Competition

    The Three Minute Thesis Competition was one of the highlights of the 10th Health Services and Policy Research Conference.  Entrants had 3 minutes to present their work with the assistance of a single power point slide.

    Competition prizes were sponsored by:

    JUDGES' CHOICE  - Tara Officer, Health Services Research Centre, Victoria University of Wellington

    "Nurse practitioners and pharmacist prescribers in primary health care:  A realist evaluation of the New Zealand experience"
    Tara Officer,

    Tara Officer (left) receiving her 3MT prize

    PEOPLE'S CHOICE  - Kristin Edwards, James Cook University

    "A data linkage and patient outcome study of aeromedical retrieval services in Central Queensland"

    Kristin Edwards (right) receiving her 3MT Award

    JHOM Editor Suzanne Robinson with the 3MT Winners

  • 2016 Award Winners

    Congratulations to our 2016 HSRAANZ Award Winners

    This year we introduced a number of new awards to recognise individuals and projects which have made significant contributions to the fields of health services research and health policy in Australia and New Zealand.
    Three competitions were held this year:
    The HSR Impact Award
    The Best HSR Paper of the Year
    The Best PhD Student of the Year

    The HSR Impact Award

    This new award recognises health services research that has had a significant impact on health and health care. The award is intended to identify and promote examples of outstanding research that has been successfully translated into health policy, management, or clinical practice.

    The standard of the nominated projects was extremely high and the judges had a very difficult task picking a winner.  The nominated projects were presented at the HSRAANZ Symposium as examples of the real world impact on health services research.

    Details of the nominated projects


    A/Prof Ian Scott and his team with their work   - “Maximising value of healthcare”.

    Dr Ian Scott collecting his award

    Dr Ian Scott collecting his award

    A/Prof Ian Scott has been the lead clinician and investigator for several major programs aimed at maximising value of healthcare that have attracted national and international interest. These include:
    • Improving access to emergency care within hospital practice – large scale tertiary hospital reform program which raised NEAT 4-hour compliance rates from 32% to 62% over 9 months (P < 0.001) in association with reduced in-hospital mortality (from 2.3% to 1.7%; P = 0.04). Many of these reforms have been implemented in other hospitals and have been presented to several health service conferences.
    • Ian was lead clinician in collaboration producing systematic review of evidence for 4-hour rule targets indicating all targets were arbitrary. Subsequent investigation of datasets from 59 Australian hospitals which found that adjusted in-hospital mortality for emergency admissions falls as 4-hour NEAT compliance rates rise to a nadir of 83%, with no further increase thereafter. This was an international first in presenting an evidence-based target of around 80% which Queensland Health adopted, with other jurisdictions considering similar moves, and researchers in the UK and New Zealand aiming to replicate in their jurisdictions.
    • Design and implementation of an integrated end of life care (EoL) program which incorporates advanced care planning (ACP) for patients with limited prognosis and which involves all hospitals, RACFs and general practices in Metro South (MS) Hospital and Health Service (HHS). More than 2600 patients have completed ACP in the last 2 years, and our methodology has been adopted by another 12 HHS and several other primary health networks. This work has been recognised by Queensland Health Minister at recent COAG meeting.
    • Publication of a sentinel paper in Australian Health Review in 2015 which articulated 10 clinician-led strategies for maximising value in healthcare, with particular focus on hospital care, which featured prominently in a Productivity Commission report later that year and presented to health departments, professional colleges and the Australian Medical Association. Research has investigated cognitive biases in clinician decision-making that predispose to low value care (accepted for publication in MJA) that has informed Queensland Clinical Senate, the Royal Australasian College of Physicians EVOLVE program and the NPS Medicine Wise Choosing Wisely campaign.
    • Inappropriate polypharmacy is a major cause of avoidable hospitalisations and Ian established the Australian Deprescribing Network in 2014 and was lead author of a sentinel article on the deprescribing process in JAMA Internal Medicine in 2015, which has been cited 104 times and adopted by various guideline groups in Australia, UK and New Zealand.
    • Emergency care of patients with suspected or definite acute coronary syndromes is a leading cause of ED presentations. As lead methodologist, Ian co-authored the recently released 2016 National Heart Foundation/Cardiac Society of Australia and New Zealand Guidelines for Acute Coronary Syndromes which comprise the first Australian guidelines satisfying all Institute of Medicine standards.

    Acknowledgements: Key collaborators: Prof Adam Elshaug, Prof Elizabeth Reymond, Assoc Professor Michelle Foster, Prof David Le Couteur, Prof Sarah Hilmer, Prof Derek Chew, Associate  Professor Ruth Hubbard, Dr Clair Sullivan, Ms Kristen Anderson, Mr Chris Freeman.


    Prof William Parsonage and his team for “The Statewide Accelerated Chest Pain Risk Evaluation (ACRE) Project”

    Dr Will Parsonage

    Dr Will Parsonage

    The Accelerated Chest Pain Risk Evaluation (ACRE) Project is a structured program of clinical redesign which has rapidly translated research into clinical practice. The project aimed to improve the assessment patients presenting to emergency departments (EDs) with chest pain and to evaluate the health service outcomes of the change in practice. The project was based on high-quality clinical evidence from locally-derived, widely cited research published in 2012 (The ADAPT trial).

    The Accelerated Chest pain Risk Evaluation (ACRE) Project is a structured program of clinical redesign which has rapidly translated research into clinical practice. The project aimed to improve the assessment patients presenting to emergency departments (EDs) with chest pain and to evaluate the health service outcomes of the change in practice. The project was based on high-quality clinical evidence from locally-derived, widely cited research published in 2012 (The ADAPT trial).

    A pilot study at a single site in Queensland was undertaken in 2013 followed by state-wide implementation in all eligible hospitals over a 2-year period from 2014 to 2016.

    Pooled data from 12 months pre-implementation and up to 16 months post-implementation has demonstrated significantly decreased ED length of stay, hospital admission rates to inpatient units and total hospital length of stay. For all patients presenting with possible cardiac chest pain median total hospital LOS fell from 1210mins to 806mins (404mins 95% CI 370-437mins). Hospital admissions fell from 70.4% to 57.3% (-13.1% 95% CI 12.3 - 13.9%). From May 2014 to the end of April 2016 51,042 patients have presented to the ED’s across the 18 sites with possible cardiac chest pain. Of these, 12,138 (24%) have been managed on the ADAPT-ADP.

    This research has resulted in substantial released capacity with economic impact evaluation suggesting savings of more than $7.5 million per year across the state.

    Adj A/Prof Prof Terri Jackson for her project on – “Using information on hospital acquired diagnoses to improve hospital care"

    A program of applied health services research in collaboration with National and State agencies to understand how routine data can be used in clinical oversight and funding. This work has informed Australian policy development, including:

    • National agreements to use pricing signals to motivate quality improvement, and to collect additional data elements in the hospital minimum dataset to identify condition-onset for hospital acquired diagnoses,
    • Demonstrations of alternative ways of using activity-based pricing mechanisms to improve quality and safety of hospital care,
    • Estimates of State-specific and national incremental costs of harmful hospital-acquired diagnoses,
    • Development of data algorithms to group hospital-acquired diagnoses for use in quality improvement (CHADx and CHADx+), and to identify coding errors in condition onset flagging,

    A/ Prof Terri Jackson

    Adj A/ Prof Terri Jackson

    • Reporting of CHADx rates in the annual Australian Hospital Statistics
    • Testing the use of routine data to report nationally-mandated sentinel events,
    • Applied studies with clinical colleagues of the risks and outcomes of hospital-acquired diagnoses in various patient subpopulations, including elective surgical patients, cancer patients, cardiac surgery patients, inpatients older than 65, spinal injury patients, patients with pre-existing diabetes and kidney failure, and neonates,
    • Studies to investigate methods of using data on multiple emergency department presentations to predict delayed or missed diagnoses, using linked data to identify readmissions attributable to a hospital-acquired diagnosis in a previous admission, and data mining techniques to measure the extent to which hospital-acquired diagnoses are associated with the patient’s reason for admission.

    The Best HSR Paper of the Year

    This year we also called for nominations from our membership for the best HSR Papers. This award recognises the best scientific works in the of field health services and policy research. We received 12 eclectic nominations, (details here) which illustrate the range of HSR being undertaken in Australia and New Zealand.  The judges were impressed by the quality and range of the work submitted and as a result they made awards in four categories:

    The Best Quantitative Paper was awarded to Andrew Partington and his collaborators for their paper “Screening for Important Unwarranted Variation in Clinical Practice: A Triple-Test of Processes of Care, Costs and Patient Outcomes”

    Andrew Partington, is Principal Project Officer, Activity Modelling and Purchasing, System Performance and Service Delivery, SA Health. Having worked as a Research Associate within the Adelaide Health Economics Group at the University of Adelaide, Andrew has spent the last couple of years as a strategy consultant within the UK National Health Service. Most recently, he joined the South Australian Department for Health & Ageing where he helps to lead state-wide commissioning initiatives.

    While his research focus includes unwarranted variations and health state valuation, Andrew is most interested in improving the way health economics is used to engage diverse decision-makers in service quality and financial sustainability initiatives.

    Andrew Partington

    Andrew Partington

    The Best Qualitative Paper was awarded to Lindy Willmott and her collaborators for their paper “Reasons doctors provide futile treatment at the end of life: a qualitative study”.

    Willmott L, White B, Gallois C, et al. J, Med Ethics 2016;42:496–503. Link

    Lindy Willmot

    Prof Lindy Willmott

    Lindy is a Professor with the Faculty of Law at the QUT and a Director of the Australian Centre for Health Law Research at QUT.  She researches in the area of health law, particularly end-of-life issues and is currently undertaking a number of empirical research projects funded by the ARC.  She is also a Chief Investigator in a NHMRC funded Centre of Research Excellence on End of Life.

    Lindy is also the author of many books across various fields of law and is one of the editors of the book ‘Health Law in Australia’.  She is a former member of the Queensland Civil and Administrative Tribunal and the Queensland Law Reform Commission.

    Rhodes Scholar Professor Ben White

    Rhodes Scholar Professor Ben White

    Professor Ben White is a Director of the Australian Centre for Health Law Research in the Faculty of Law at the Queensland University of Technology (QUT).

    Ben graduated with first class Honours and a University Medal in Law from QUT and then completed a DPhil at Oxford University on a Rhodes Scholarship. Before joining the Law Faculty, he worked as an associate at the Supreme Court and at Legal Aid Queensland. Between 2005 and 2007, Ben was appointed as the full-time Commissioner of the Queensland Law Reform Commission where he had carriage of the Guardianship Review on behalf of the Commission. He also served as a part-time Commissioner between 2007 and 2010.

    Ben’s area of research focus is end of life decision-making and he is undertaking a number of Australian Research Council funded studies examining law at the end of life. He is currently a committee member of the Australasian Association of Bioethics and Health Law and an editor of ‘Health Law in Australia’

    The Best Paper by an Early Career Researcher was won by Emily Karanges and her collaborators for their paper “Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims”.

    Br J Clin Pharmacol. 2016 Jul;82(1):255-67. doi: 10.1111/bcp.12937. Epub 2016 May 7. Link

    Emily Karanges

    Emily Karanges

    Dr Emily Karanges is a research fellow in the Medicines Policy Research Unit within the Centre for Big Data Research in Health. Her research focus concerns the pharmacoepidemiology of psychotropic medicine use. While her research extends to all age groups, Emily has a particular interest in the use of psychotropics in children, adolescents and young adults. She is also interested in the pharmacoepidemiology of opioid analgesics.

    Emily also has expertise in the field of psychopharmacology. In 2015 she received her PhD in behavioural neuroscience, psychopharmacology and psycho-pharmacoepidemiology at the University of Sydney. Her thesis was primarily concerned with the behavioural and neurobiological effects of antidepressant treatment during adolescence.

    The Best New Zealand Paper was awarded to Robin Gauld and Simon Horsburgh and their paper “Does a host country capture knowledge of migrant doctors and how might it? A study of UK doctors in New Zealand”.

    Int J Public Health (2016) 61:1-8 DOI 10.1007/s00038-015-0770-z Link

    Robin Gauld

    Prof Robin Gauld

    Robin Gauld is Professor of Health Policy in the Department of Preventive and Social Medicine, and Director of the Centre for Health Systems—that spans the School of Business and the Dunedin School of Medicine.

    He was a Senior Fellow at the Boston University Health Policy Institute from 2009–2013, and a Commonwealth Fund Harkness Fellow in 2008–2009, working with colleagues from Boston University and Harvard University. In 2014, he was NZ-UK Link Foundation Visiting Professor at the School of Advanced Study, University of London.

    Past positions include lecturing and research posts at the University of Hong Kong and City University of Hong Kong, and teaching at the University of Texas and Harvard University.

    Current research interests include: comparative health policy, health system and quality improvement, clinical governance, primary care, population based health funding formulas, and health information technology.

    On 1 Dec 2016 he takes up a new role at the University of Otago as Pro-Vice-Chancellor Commerce and Dean of the School of Business.

    Dr Simon Horsburg

    Dr Simon Horsburgh is a senior lecturer in Epidemiology in the Department of Preventive and Social Medicine at the University of Otago.

    Simon's primary research focus is pharmacoepidemiology, particularly in the area of using routinely-collected data to study medicines utilisation and access.

    He has also collaborated with Professor Gauld to examine health workforce issues such as clinical leadership and workforce migration.

    Dr Horsburgh is a founding member of the Pharmacoepidemiology Research Network, as well as an associate of the Centre for Health Systems. He serves as an associate editor for BMC Health Services Research.

    Best PhD Student.

    Our final award was for the Best PhD Student and recognizes up and coming health services researchers.   The nominated papers were judged on the author’s ability to:

    • write clearly and concisely,
    • to present ideas and arguments logically,
    • to use appropriate, sound methods; and
    • to show how their results are relevant to policy and/or practice.

    Details of all of the nominated papers can be viewed here.  Once again the judges were impressed with the quality of all the nominated work which bodes well for future capacity in HSR.



    Michael Falster of the Centre for Big Data Research in Health, UNSW Australia for his work “Sociodemographic and health characteristics, rather than primary care supply, are major drivers of geographic variation in preventable hospitalizations in Australia”,.9.aspx

    Michael Falster is a Biostatistician and Research Fellow at the Centre for Big Data Research in Health (CBDRH) at UNSW Australia where he is also completing his PhD . Michael has over 10 years’ experience working in public health, biostatistics and epidemiological research, and is currently project coordinator on the Assessing Preventable Hospitalisation InDicators (APHID) Study, an NHMRC funded partnership grant using linked data to explore contributors to geographic variation in ‘preventable’ hospitalisations.

    Michael’s work and interests are characterized by finding innovative statistical methods for quantifying and exploring variation in health and health care, such as: multilevel models for deconstructing geographic variation in health inequalities and outcomes; data visualizations exploring temporal patterns of health events; spatial methods for identifying and analyzing hospital patient catchments; and data algorithms for characterizing longitudinal patterns of healthcare use.

    Michael Falster

    Michael Falster

    Michael has experience in diverse fields such as health services research, injury, Aboriginal health, cancer epidemiology and perinatal research, and experience analyzing complex linked data sources including survey, hospital, Medicare, mortality, perinatal, cancer notification and emergency department data sets. Having a background in health, policy and statistics, Michael is interested in translating complex statistical methods and findings towards a policy audience.


     Elizabeth Whittaker from the National Drug and Alcohol Research Centre, UNSW for her work “Associations of Housing First Configuration and Crime and Social Connectedness Among Persons with Chronic Homelessness Histories”.

    Elizabeth Whittaker

    Elizabeth Whittaker

    Liz Whittaker is submitting her PhD this year, which has examined vulnerable homeless sub-groups and the impacts of Housing First configurations. Liz has worked on a number of homelessness and housing evaluations at the National Drug and Alcohol Research Centre at UNSW Australia, where she also co-ordinated the Northern Territory Ecstasy and Related Drugs Reporting System (EDRS). Liz has recently secured a Senior Policy Officer role with NSW Government Family and Community Services designing the evaluation of the Out of Home Care reforms.

    The projects nominated for the Best Impact Award were presented at the HSRAANZ Symposium.

    We will be reporting in more detail on the other winning research on the HSRAANZ Blog, over the next couple of weeks.

  • HSRAANZ Professional Award

    This Award was presented biennially from 2011 and 2015 and recognised an individual who had made an outstanding, life-time contribution to the development of health services research in Australia or New Zealand. The Award recognised the conduct of high quality health services research, translation into policy and practice, and activities to support other researchers, such as mentoring and contributing to the development of a supportive research environment.

    Previous Winners

    2015 Winner - Professor Kathy Eagar, Director of the Australian Health Services Research Institute (AHSRI), University of Wollongong.

    Read the Croakey interview with Kathy

    2013 Winner - Prof Jacqueline Cumming University of Victoria, Wellington

    2011 Winner - Prof Jane Hall, University of Technology Sydney

    Read our 2011 interview with Prof Jane Hall

    This Award has been replaced with the Distinguished Investigators Awards.


    The Purpose of the HSRAANZ Professional Award is to:

    Identify and acknowledge individuals who have made an outstanding contribution to the development of health services research in Australia or New Zealand

    Profile the work of the individual

    Inspire others to follow the example

    Criteria for Selection—The award is be offered to an individual who has:

    Initiated a strong research agenda

    Made an ongoing contribution to the profession of health services research over many years

    Mentored other researchers

    Contributed to a supportive research environment.

  • Awards Presented at the HSRAANZ Conference

    Best PhD Student Prize

    This prize was awarded biennially, at HSRAANZ Annual General Meeting. It has been replaced with the new Health Services and Policy Research Paper of the Year Award

    Previous Winners
    Katherine Elkin
    Paul Harris

    The ERGO Best Poster and Oral Presentation Prizes

    These awards previously made at the Health Services and Policy Research Conference have been replaced by the Early Career Researchers 3 Minute Presentation Competition and the Best Abstract and Poster Prizes.

    2013 Prize Winners
    2011 Prize Winners
    2009 Prize Winners

Dr Elizabeth Lynch

Dr Elizabeth Lynch is an experienced stroke rehabilitation physiotherapist. She has been awarded state and national awards for her work implementing evidence-based practices in stroke rehabilitation settings.

Liz completed her PhD in 2015, which used mixed methods to explore and improve how rehabilitation needs are assessed after stroke. She was awarded an NHMRC Early Career Research Fellowship (commenced 2018) and she is currently investigating how to effectively implement the 2017 Stroke Clinical Guidelines and how partnerships with patients can be incorporated into implementation projects.  Liz is based at the Adelaide Nursing School, University of Adelaide and is affiliated with the NHMRC Centre of Research Excellence in Stroke Rehabilitation and Brain Recovery.

“Assessing and managing rehabilitation needs of people with stroke in Australia”

This program of research investigated the implementation of the nationally recommended Assessment for Rehabilitation Tool that was disseminated in 2012. The Assessment for Rehabilitation Tool is a patient-centred, evidence-based decision-making tool that can help determine whether a person has rehabilitation needs and how these can best be managed. A cluster-randomised trial was conducted at 10 hospitals in South Australia and New South Wales, comparing the effectiveness of education-only to a multifaceted intervention. Data were collected from all participating sites about how the Assessment Tool was being used, and factors affecting its use. This work highlighted that judgements were being made about a person’s rehabilitation potential based primarily on whether services were available to meet a person’s needs – people whose needs fell outside the scope of the usual services (e.g. people with severe stroke, people with reduced alertness) often did not have rehabilitation needs identified and were not referred to a rehabilitation service, despite evidence that this cohort can improve independence and quality of life with rehabilitation.

Elizabeth has:

• Presented the findings to consumer, clinical and research audiences.

• Acted in a consultancy role with Australia’s peak stroke body, the Stroke Foundation, to advise on wording of the National Stroke Audit. This has enabled the collection of information about how rehabilitation needs are being identified and managed, and objective reasons why rehabilitation is not indicated or why rehabilitation is not accessed.

• Provided advice and mentoring to clinicians in three states of Australia regarding how to implement the Assessment for Rehabilitation Tool, so clinicians are empowered and confident to conduct patient-centred, evidence-based assessments, and refer to rehabilitation according to patients’ rehabilitation needs.

• Contributed to the updating the Australian Stroke Clinical Guidelines and was nominated to lead the section regarding assessment of rehabilitation needs. The Stroke Clinical Guidelines now explicitly recommend use of the Assessment for Rehabilitation Tool, and recommend that every person with rehabilitation needs be referred to a rehabilitation service. The impact of the new Stroke Clinical Guidelines has yet to be evaluated.

Professor Anthony Scott

Anthony Scott leads the Health Economics Research Program at the Melbourne Institute of Applied Economic and Social Research at the University of Melbourne. He has a PhD in Economics from the University of Aberdeen. He is an Associate Editor of Journal of Health Economics, Health Economics, and Social Science and Medicine, President of the Australian Health Economics Society, and a member of the Board of the International Health Economics Association. He is a Fellow of the Academy of the Social Sciences in Australia. He has been an ARC Future Fellow and NHMRC Principal Research Fellow. Tony’s research interests focus on the behaviour of physicians, health workforce, incentives and performance, primary care, and hospitals. He has consulted and provided advice to the World Bank, Independent Hospital Pricing Authority, Productivity Commission, Medibank Private, and Commonwealth and State Departments of Health. He leads the Medicine in Australia: Balancing Employment and Life (MABEL) panel survey of 10,000 physicians, and is a Research Lead Investigator on the NHMRC Partnerships Centre on Health System Sustainability.   

Medicine in Australia: Balancing Employment and Life (MABEL)

Medicine in Australia: Balancing Employment and Life (MABEL) is Australia’s national panel survey of 10,000 doctors. Now running for over 11 annual Waves, MABEL is designed to improve access to health care by influencing the geographic distribution of doctors, and understanding workforce participation, doctor’s career choices, and working patterns.   The latest Wave 11 included new questions on doctor’s health and wellbeing and use of electronic shared records and video consultations.  MABEL survey data are also linked to MBS and PBS data.


MABEL’s most notable impact to date was the use of MABEL data to develop the Modified Monash Model (MMM), a new geographic classification scheme to allocate funding to medical workforce programs in rural areas.  MMM was proposed by MABEL Chief Investigators Emeritus Prof. John Humphreys (Monash University) and Dr. Matthew McGrail (The University of Queensland) as part of a submission to a Senate Enquiry.  This was based on a paper published using MABEL data to describe how GP workload varied by population size.  MMM was adopted and first used by the Department of Health in 2015, and is now applied to over 15 workforce programs that allocate over $1bn to support access to medical care rural areas in Australia. The measure has continuing strong support from the rural health sector and from the Commonwealth Department of Health. In addition, MABEL data are regularly used by researchers and key medical workforce stakeholders, including medical colleges, to provide evidence and data on a range of current issues within the medical workforce, including evidence on policies to support access to medical care in rural areas.  De-identified MABEL data are provided to external researchers at minimal cost to maximise the use of the data. We have 260 external data users from across Australia, and receive 2-3 data requests per month.


Impact Summary





Funding acknowledgement. NHMRC (2008 to 2015), Department of Health (2018-19), The University of Melbourne (2017-18), Health Workforce Australia (2013), Medibank Private Better Health Foundation (2017), DHHS (2017-18), NSW Health (2017), Australian Digital Health Agency (2018-19).

Dr Alison Pearce

Alison Pearce is a health economist interested in the various costs of cancer. Her research aims to use health services research and health economics to improve cancer care by providing relevant, reliable information for decision making. Currently based at the University of Sydney School of Public Health, Alison teaches introductory health economics and conducts research in the areas of oncology patient preferences and productivity loss. Alison’s original training was in occupational therapy, and she remains interested in rehabilitation research. She also has keen interests in early career researcher development, communicating research to the public, and the use of social media in academia.

‘Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison’


Background: Over two-thirds of the world’s cancer deaths occur in economically developing countries; however, the societal costs of cancer have rarely been assessed in these settings. Our aim was to estimate the value of productivity lost in 2012 due to cancer-related premature mortality in the major developing economies of Brazil, the Russian Federation, India, China and South Africa (BRICS).

Methods: We applied an incidence-based method using the human capital approach. We used annual adult cancer deaths from GLOBOCAN2012 to estimate the years of productive life lost between cancer death and pensionable age in each country, valued using national and international data for wages, and workforce statistics. Sensitivity analyses examined various methodological assumptions.

Results: The total cost of lost productivity due to premature cancer mortality in the BRICS countries in 2012 was $46·3 billion, representing 0·33% of their combined gross domestic product. The largest total productivity loss was in China ($28 billion), while South Africa had the highest cost per cancer death ($101,000). Total productivity losses were greatest for lung cancer in Brazil, the Russian Federation and South Africa; liver cancer in China; and lip and oral cavity cancers in India.

Conclusion: Locally-tailored strategies are required to reduce the economic burden of cancer in developing economies. Focussing on tobacco control, vaccination programs and cancer screening, combined with access to adequate treatment, could yield significant gains for both public health and economic performance of the BRICS countries.


(Acknowledgement – Alison’s research was funded by an Irish Health Research Board ‘Interdisciplinary Capacity Enhancement Award’ and by the COST Action CANWON for a ‘Short Term Scientific Mission’ to the WHO International Association for Research on Cancer)

Dr Haitham Tuffaha

Dr Haitham Tuffaha is NHMRC and Senior Research Fellow in Health Economics at Griffith University, Australia. Haitham holds an MSc degree in Clinical Pharmacy (with Distinction) from Strathclyde University in Glasgow, an MBA degree from Wollongong University in NSW and a PhD in Health Economics from Griffith University. His research encompasses the economic evaluation of health care technologies with an interest in Value of Information analysis as a systematic approach to inform reimbursement decisions, optimise trial design and prioritise research funding.

After completing his PhD in 2016, Haitham has rapidly established a high-quality track record and built a reputation as a promising leader in his field of research. He has over 50 peer-reviewed journal articles, book chapters and technical reports. He has published in leading journals including The Lancet, Nature Genetics in Medicine, Value in Health, PharmacoEconomics and the Medical Journal of Australia. His research has influenced health policy and clinical practice nationally and internationally.

Haitham is the Chair of the Clinical Oncology Society of Australia’s (COSA)-Epidemiology Group, the Co-Chair of Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group and Secretary of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Australian Chapter. He is an Editorial Board Member of PharmacoEconomics-Open and a regular reviewer for leading journals.


Jonathan is a staff specialist in clinical pharmacology, toxicology and addiction at St. Vincent’s Hospital and a post-graduate fellow in clinical toxicology at NSW Poison Information Centre . He completed a PhD at the Centre for Big Data Research in Health on the use of PBS dispensing claims to measure the quality use of medicines. He is a tutor on masters courses in toxicology and health data and sits on the Drug Utilisation Sub Committee of the PBAC. 

Tim Badgery-Parker

Tim Badgery-Parker is completing his PhD in the Menzies Centre for Health Policy, The University of Sydney. His research focuses on measuring low value care, defined by Choosing Wisely, RACP EVOLVE, or similar recommendations, in the NSW public hospital system. Tim previously worked as a biostatistician in the Centre for Epidemiology and Evidence, NSW Ministry of Health, and then in the Cancer Epidemiology and Services Research Group and the Surgical Outcomes Research Centre in the Sydney School of Public Health.

Skip to toolbar